From the Bench

Understanding FDA Cell and Gene Therapy Guidance

The CRISPR gene therapy regulatory space is changing rapidly. In this blog, we’re covering the latest cell and gene therapy news, including updated FDA guidances.

Rebecca Roberts, Ph.D.

Lina Jamis, M.S.

Clinical CRISPR Solutions

CRISPR Clinical Trials to Follow

CRISPR Conversation

The Groundbreaking Approval of Casgevy, the First CRISPR Therapy in the US

CRISPR Applications

CRISPR Off-Target Editing: Prediction, Analysis, and More

All Articles

A Deep Dive into CRISPR Applications in Immuno-Oncology with Imran House and Junyun Lai

CRISPR Cuts Podcast

Dina Simkin Discusses Epilepsy Modeling in Patient-Derived Stem Cells

CRISPR Cuts Podcast

Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia

CRISPR Applications

Alternatives to CRISPR-Cas9: Nucleases for Next-Gen Therapy

SHOWING 12 OF 147

Learn more about CRISPR with these free assets

Explore our technologies and learn more about CRISPR genome engineering benefits, techniques, and more.

Explore Resources

From the Bench

Understanding FDA Cell and Gene Therapy Guidance

CRISPR Clinical Trials to Follow

The Groundbreaking Approval of Casgevy, the First CRISPR Therapy in the US

CRISPR Off-Target Editing: Prediction, Analysis, and More

Get the Latest in CRISPR

All Articles

Explore by topic

Understanding FDA Cell and Gene Therapy Guidance

CRISPR Clinical Trials to Follow

The Groundbreaking Approval of Casgevy, the First CRISPR Therapy in the US

CRISPR Off-Target Editing: Prediction, Analysis, and More

How to Order Engineered Cells, Multi-Guide GKO Kits, and Screening Libraries

Demystifying CRISPR gRNA Chemical Modifications

Unlocking the IP Benefits of Novel Nucleases in CRISPR Therapies

CRISPR Cystic Fibrosis Research: Hope For Genomic Medicines

A Deep Dive into CRISPR Applications in Immuno-Oncology with Imran House and Junyun Lai

Dina Simkin Discusses Epilepsy Modeling in Patient-Derived Stem Cells

Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia

Alternatives to CRISPR-Cas9: Nucleases for Next-Gen Therapy

Learn more about CRISPR with these free assets